ArticleFrontiers in immunology2025
Splenectomy modulates intrarenal B cell differentiation and impairs repair of post-ischemic kidney.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lymphocytes are known to regulate kidney repair after ischemia-reperfusion injury (IRI). Splenectomy has been proposed as a preconditioning protocol for high-risk kidney transplantation and has been suggested to affect IRI outcomes. However, the role of splenectomy in IRI repair remains poorly understood. This study investigated the effects of splenectomy on the immunological microenvironment in a mouse model of kidney IRI. Methods: C57BL/6 mice underwent severe (45 min) unilateral (left) IRI and were divided into two groups: IRI surgery alone (IRI group) and IRI surgery with simultaneous splenectomy (IRI+SPX group). Post-ischemic and contralateral kidneys were collected on days 10 and 30 after IRI. Kidney function, histology, lymphocyte population (analyzed by flow cytometry), and cytokine/chemokine expression were evaluated. Results: The plasma creatinine levels were higher in the IRI+SPX group on day 10, while the cystatin C concentrations were not significantly different between the two groups. The percentage of tubular damage and fibrosis in post-ischemic kidneys during the repair phase was significantly higher in the IRI+SPX group than in the IRI group. While the T cell profiles were comparable between the groups, the proportions of activated B cells and MHCII+ B cells in the post-ischemic and contralateral kidneys were higher in the IRI+SPX group on day 30 after IRI. The expressions of IL-17, MCP-1, and TGF-β in post-ischemic kidneys were higher in the IRI+SPX group compared with the IRI group. Discussion: Splenectomy exacerbates tubular damage and fibrosis during the repair phase of severe IRI and significantly alters the immunological microenvironment of the kidneys, promoting B cell differentiation. Our study suggests that splenectomy may worsen outcomes in IRI, and further studies investigating potential reparative pathways through the kidney-spleen axis are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.